Results 171 to 180 of about 36,516 (242)

Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in Chondrosarcoma. [PDF]

open access: yesInt J Mol Sci
Zając AE   +20 more
europepmc   +1 more source

Utilizing bulk and single-cell RNA sequencing to identify potential biomarkers linked to angiogenesis and integrated stress response in chondrosarcoma. [PDF]

open access: yesSci Rep
Li S   +14 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Chondrosarcoma.

Journal of the American Academy of Orthopaedic Surgeons, 2021
Chondrosarcoma is the second most common primary bone tumor, with >90% of cases representing the primary conventional subtype. In addition to arising de novo, conventional chondrosarcoma can arise secondary to a benign underlying lesion, such as ...
Robert C. Weinschenk   +2 more
semanticscholar   +3 more sources

The role of surgical margins in chondrosarcoma

European Journal of Surgical Oncology, 2018
INTRODUCTION Chondrosarcoma (CS) is the second most common primary bone sarcoma with no clear role for adjuvant therapy. The purpose of this study was to investigate (1) the relationship between surgical excision margins and local recurrence free ...
Michael Parry   +2 more
exaly   +2 more sources

Melatonin inhibits chondrosarcoma cell proliferation and metastasis by enhancing miR‐520f‐3p production and suppressing MMP7 expression

Journal of Pineal Research, 2023
Chondrosarcoma has a high propensity to metastasize and responds poorly to chemotherapy and radiation treatment. The enzymatic activity of matrix metalloproteinases (MMPs) is very important in chondrosarcoma metastasis.
N. Tran   +11 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy